Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$78.6M
+59.5% from 2023
Prescriptions
4,990
$15,752.09 per claim
Patients
629
559 prescribers
Total spending, 2024
$78.6M
$124,964.90 per patient
Medicare prescription drug plans paid $78.6M for Sodium Oxybate in 2024, for 4,990 prescriptions and refills to 629 patients (up 59.5% from 2023). The average cost per claim was $15,752.09.
Florida had the highest Medicare cost for Sodium Oxybate in 2024: $5.5M for 341 claims, followed by California ($5.0M).
Natalio J Chediak, neurology in Boca Raton, FL, had the highest Medicare cost for Sodium Oxybate in 2024: 73 claims costing $970K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Natalio J Chediak Boca Raton, FL | Neurology | 73 | Under 11 | $970K |
| Oneil S Bains Seattle, WA | Sleep Medicine | 45 | Under 11 | $819K |
| Mujahid M Mahmood |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2023 | 425 | 3,308 | 477 | $49.3M |
| 2024 | 559 | 4,990 | 629 | $78.6M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims |
|---|
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Neurology |
| 48 |
| Under 11 |
| $789K |
| Kirk G Watkins St George, UT | Sleep Medicine | 45 | Under 11 | $677K |
| Andrew P Gasecki Sandy, UT | Neurology | 36 | Under 11 | $628K |
| Shane C Concepcion Austin, TX | Certified Clinical Nurse Specialist | 37 | Under 11 | $610K |
| Donald S Howard Spokane, WA | Sleep Medicine | 34 | Under 11 | $565K |
| Thomas E Scammell Boston, MA | Neurology | 39 | Under 11 | $564K |
| Brian H Moore Bloomington, IN | Neurology | 39 | Under 11 | $556K |
| Richard K Bogan Columbia, SC | Pulmonary Disease | 39 | Under 11 | $555K |
| Adrian A Santamaria Tomball, TX | Neurology | 30 | Under 11 | $535K |
| Jaime A Boero Marshfield, WI | Neurology | 31 | Under 11 | $528K |
| David T Plante Madison, WI | Psychiatry | 33 | Under 11 | $528K |
| John F Trapp Lincoln, NE | Pulmonary Disease | 28 | Under 11 | $521K |
| John S Kim Columbus, OH | Sleep Medicine | 32 | Under 11 | $521K |
| David Y Huang Tallahassee, FL | Pulmonary Disease | 27 | Under 11 | $493K |
| Patrick J Wright Minneapolis, MN | Pulmonary Disease | 25 | Under 11 | $457K |
| Steve T Kirk Durham, NC | Neurology | 28 | Under 11 | $456K |
| Richard P Millman Riverside, RI | Sleep Medicine | 28 | Under 11 | $409K |
| Jonathan A Marcus Rochester, NY | Neurology | 24 | Under 11 | $406K |
| Richard C Hammond Ogden, UT | Neurology | 26 | Under 11 | $401K |
| Elaine L Chen South Pasadena, CA | Physician Assistant | 23 | Under 11 | $392K |
| James B Haynes Nashville, TN | Pulmonary Disease | 24 | Under 11 | $388K |
| Baba H Limann Lemoyne, PA | Pulmonary Disease | 20 | Under 11 | $376K |
| Halina Pritula Marion, OH | Neurology | 20 | Under 11 | $376K |
| Spending |
|---|
| Hikma Pharmaceu HIK.L | 4,792 | $75.7M |
| Amneal Pharmace AMRX | 198 | $2.9M |